ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Zentalis Pharmaceuticals Announces Closing of Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 02, 2021Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) today announced the closing of an underwritten public offering of 3,565,000 shares of its common stock at a public offering price of $48.50 per share. -
Zentalis Pharmaceuticals Announces Proposed Public Offering of Common Stock
June 29, 2021Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) today announced the commencement of a proposed underwritten public offering of $150 million of shares of its common stock.
Pharma Sources Insight January 2025
